A retrospective review of undifferentiated malignancy in childhood
- PMID: 2198823
- DOI: 10.1097/00043426-199022000-00003
A retrospective review of undifferentiated malignancy in childhood
Abstract
We reviewed the experience of children with "undifferentiated" cancer at The Children's Hospital of Pittsburgh (CHP) from 1971 through 1987. Of 2,095 patients 0-18 years old with diagnoses during that time of any cancer, the initial CHP pathology report rendered a diagnosis in 22 children (1.1%) of "undifferentiated malignancy" or "malignant tumor" (15 cases), "undifferentiated carcinoma" (two cases) or "anaplastic tumor or carcinoma" not otherwise specified (five cases). A review of pathologic findings using current methods and immunostaining led to the assignment of a specific diagnosis in 15 of the 20 cases so studied. Thus, the incidence of undifferentiated cancer by current criteria was reduced to no more than 0.23%. Two of the five tumors for which an alternative diagnosis could not be established were described as "rhabdoid," but because it is not clear that these tumors fit into a single category they were still considered to be undifferentiated. Clinical features and management of the 22 cases including the five persistently diagnosed as undifferentiated malignancy were heterogeneous. In the face of reassigned diagnoses, a number of patients would likely have received different chemotherapy as well as radiation. Nonetheless, seven patients with malignancy show no evidence of disease (NED), including several whose therapy, given the current best diagnosis, would not be considered to have been optimal. We recommend that for patients undergoing biopsy of a tumor, sufficient material be obtained for extensive pathologic evaluation. In this way, the diagnosis of undifferentiated malignancy in children can be almost eliminated.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Extracranial malignant rhabdoid tumors in childhood: the Childrens Hospital Los Angeles experience.Cancer. 2007 Nov 1;110(9):2061-6. doi: 10.1002/cncr.23020. Cancer. 2007. PMID: 17828773
-
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Epidemiol Prev. 2016. PMID: 26951748
-
Volumetric considerations in radiotherapy for pediatric parameningeal rhabdomyosarcomas.Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1294-9. doi: 10.1016/s0360-3016(02)04290-6. Int J Radiat Oncol Biol Phys. 2003. PMID: 12654440 Review.
-
Iridium afterloading curietherapy in the treatment of pediatric malignancies. The Institut Gustave Roussy experience.Cancer. 1985 Sep 15;56(6):1274-9. doi: 10.1002/1097-0142(19850915)56:6<1274::aid-cncr2820560609>3.0.co;2-8. Cancer. 1985. PMID: 4027867
-
Incidence of NUT carcinoma in Western Australia from 1989 to 2014: a review of pediatric and adolescent cases from Perth Children's Hospital.BMC Cancer. 2021 Jun 27;21(1):740. doi: 10.1186/s12885-021-08432-0. BMC Cancer. 2021. PMID: 34176480 Free PMC article. Review.
Cited by
-
Partial response to carboplatin, etoposide phosphate, and atezolizumab in a pediatric patient with high-grade metastatic tumor with rhabdoid and focal neuroendocrine features.Pediatr Blood Cancer. 2020 Feb;67(2):e28048. doi: 10.1002/pbc.28048. Epub 2019 Nov 13. Pediatr Blood Cancer. 2020. PMID: 31724272 Free PMC article. No abstract available.
-
A case study of an integrative genomic and experimental therapeutic approach for rare tumors: identification of vulnerabilities in a pediatric poorly differentiated carcinoma.Genome Med. 2016 Oct 31;8(1):116. doi: 10.1186/s13073-016-0366-0. Genome Med. 2016. PMID: 27799065 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources